Pfizer R&D Chief: Third dose may be needed within 6-12 months after full vaccination

Pfizer's Research and Development Chief says they continue to believe it is likely that a third dose booster may be needed within six to 12 months after full COVID-19 vaccination, Reuters reported on Wednesday, citing prepared remarks.

Additional takeaways

"Anticipating emergency use authorization submission for COVID-19 vaccine booster as early as August."

"In ongoing discussions with regulatory agencies regarding potential third dose booster of current COVID-19 vaccine."

"Planning to start immunogenicity and safety study in August to evaluate updated version of COVID-19 vaccine designed to target the delta variant."

"Projecting potential US emergency use authorization submission for oral COVID-19 anti-viral in Q4."

"Expecting to have safety & immunogenicity data to support US emergency use authorization for use in children ages 5 to 11 years old by end of September."

Market reaction

These comments don't seem to be having a significant impact on market sentiment. As of writing, S&P Futures were flat on the day at 4,394.